AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
PowderJect Awarded $1 Million Grant For Development Of HIV DNA Vaccine.(Brief Article)
2001 NOV 14 - (NewsRx.com & NewsRx.net) -- PowderJect Pharmaceuticals Plc (PJP), a specialty vaccines company, and its wholly owned subsidiary PowderJect Vaccines Inc., have, in association with the University of Pittsburgh, been awarded $1 million to support the development of a powdered DNA vaccine against HIV. The funding, which was awarded by the U.S. National Institute of Allergy and Infectious Diseases, is for a one-year period starting October 2001.
The award will support the development of PowderJect's novel DNA vaccine approaches, including the use of proprietary DNA adjuvants designed to enhance cellular and mucosal immune responses that are thought to be important to treat HIV. This work follows on from promising results achieved in earlier preclinical studies, which the company announced last year. In these studies, DNA vaccination via the needle-free PowderJect system demonstrated qualities that scientists believe will be required by an effective HIV vaccine. The research showed that powder-form DNA immunization offered protection against different virus variants ...
- Powderject DNA vaccine achieves protective immunity.(Brief Article)
- Newspaper article from: BIOTECH Patent News April 1, 2001 700+ words
...The study is part of PowderJect's major DNA vaccine collaboration with GlaxoSmithKline...tolerability) of the novel PowderJect hepatitis B DNA vaccine in those who failed to...doses in total. The PowderJect DNA vaccine proved highly immunogenic...
- PowderJect DNA Vaccine First to Achieve Protective Immunity in Non-Responders...
- Press release article from: PR Newswire April 24, 2001 700+ words
...The study is part of PowderJect's major DNA vaccine collaboration with GlaxoSmithKline...tolerability) of the novel PowderJect hepatitis B DNA vaccine in those who failed to...doses in total. The PowderJect DNA vaccine proved highly immunogenic...
- PowderJect Commences First European Clinical Trial in Healthy Volunteers With A...
- Press release article from: PR Newswire September 1, 1999 700+ words
...Phase I Study of Needle-Free PowderJect DNA Vaccine for Malaria OXFORD, England...now studying a total of three PowderJect DNA vaccines in clinical trials. Recently, PowderJect Hepatitis B DNA Vaccine completed a break-through...
- PowderJect & Glaxo Wellcome Sign DNA Vaccine Agreement
- Press release article from: PR Newswire March 4, 1998 700+ words
...a Hepatitis B DNA vaccine based upon the proprietary PowderJect System with options...products using PowderJect technology...B therapeutic DNA vaccine; * HIV therapeutic...synergistic. PowderJect's DNA vaccine technology provides...
- PowderJect's Hepatitis B DNA Vaccine First to Successfully Elicit Protective...
- Press release article from: PR Newswire December 7, 1998 700+ words
...subsidiary PowderJect Vaccines Inc...prophylactic DNA vaccine, the first...milestone for our DNA vaccine program, and...Wellcome/PowderJect team achieved...one of eleven DNA vaccine fields covered by PowderJect's agreement...
- PowderJect Announces Second Expansion of Glaxo Wellcome DNA Vaccine Alliance.
- Press release article from: PR Newswire June 17, 1999 700+ words
...owned subsidiary, PowderJect Vaccines Inc...two additional DNA vaccine licenses for HIV...include two new DNA vaccine licenses emphasizes...commitment to the PowderJect System," stated...B prophylactic DNA vaccine is the lead exploratory...important part of ...
- Glaxo Wellcome and PowderJect to Expand DNA Vaccine Collaboration.
- Press release article from: PR Newswire January 22, 1999 700+ words
...right to use PowderJect technology...prophylactic DNA vaccine for hepatitis...the following DNA vaccine products using PowderJect technology...immunity with a DNA vaccine in a human...important part of PowderJect's pipeline...
- Powderject Announces Positive Clinical Data Demonstrating Cellular Immunity...
- Press release article from: PR Newswire March 30, 1999 700+ words
...owned subsidiary, PowderJect Vaccines Inc...immunity with a DNA vaccine delivered to skin with the PowderJect(R) System...a prophylactic DNA vaccine to prevent Hepatitis...exploratory candidate in PowderJect's alliance with...